AbCellera Biologics Inc.
ABCL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703057
In the last 90 days, AbCellera Biologics Inc. insiders filed 4 open-market purchases and 0 sales; 150 institutions reported holding it in 13F filings for Q2 2026, worth $908.8M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in AbCellera Biologics Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 130
- +7 vs. Q4 2021
- Shares held
- 113.5M
- −1.05M (−0.9%) vs. Q4 2021
- Total value
- $1.10B
- −$524.1M (−32.2%) vs. Q4 2021
- New holders
- 28
- 41 more added
- Sold out
- 21
- 36 more reduced
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ABCL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 150 | $908.8M |
| Q1 2026 | 138 | $434.0M |
| Q4 2025 | 144 | $370.6M |
| Q3 2025 | 141 | $524.6M |
| Q2 2025 | 128 | $370.6M |
| Q1 2025 | 129 | $280.1M |
| Q4 2024 | 146 | $333.9M |
| Q3 2024 | 139 | $274.6M |
| Q2 2024 | 148 | $338.3M |
| Q1 2024 | 154 | $547.4M |
| Q4 2023 | 143 | $681.1M |
| Q3 2023 | 138 | $551.8M |
| Q2 2023 | 170 | $809.1M |
| Q1 2023 | 183 | $980.7M |
| Q4 2022 | 203 | $1.30B |
| Q3 2022 | 190 | $1.21B |
| Q2 2022 | 162 | $1.26B |
| Q1 2022 | 130 | $1.10B |
| Q4 2021 | 124 | $1.63B |
| Q3 2021 | 116 | $1.98B |
| Q2 2021 | 114 | $1.99B |
| Q1 2021 | 86 | $2.42B |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding AbCellera Biologics Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 393,136 | $3.83M | 0.00% | −107,834−21.5% | Reduced |
| Canada Pension Plan Investment Board | 393,776 | $3.84M | 0.01% | −41,624−9.6% | Reduced |
| Founders Fund Growth Management, LLC | 407,017 | $3.97M | 4.48% | 00.0% | Unchanged |
| Standard Life Aberdeen plc | 410,452 | $4.00M | 0.01% | −59,826−12.7% | Reduced |
| TD Waterhouse Canada Inc. | 356,626 | $4.28M | 0.04% | +175,671+97.1% | Added |
| Botty Investors LLC | 461,289 | $4.50M | 1.55% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 495,984 | $4.84M | 0.01% | −19,616−3.8% | Reduced |
| Polar Asset Management Partners Inc. | 628,130 | $6.12M | 0.08% | +628,130 | New |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 659,750 | $6.43M | 0.29% | 00.0% | Unchanged |
| Royal Bank of Canada | 827,293 | $8.07M | 0.00% | −17,069−2.0% | Reduced |
| Intellectus Partners, LLC | 1,111,979 | $10.8M | 3.24% | −80,400−6.7% | Reduced |
| Parametric Portfolio Associates LLC | 1,150,000 | $11.2M | 0.01% | −850,000−42.5% | Reduced |
| Federated Hermes, Inc. | 1,288,000 | $12.6M | 0.03% | +460,153+55.6% | Added |
| Millennium Management LLC | 1,493,996 | $14.6M | 0.02% | +797,635+114.5% | Added |
| Alyeska Investment Group, L.P. | 1,731,812 | $16.9M | 0.19% | +314,449+22.2% | Added |
| BlackRock Inc. | 2,447,299 | $23.9M | 0.00% | +80,057+3.4% | Added |
| Renaissance Technologies LLC | 2,617,603 | $25.5M | 0.03% | +2,078,400+385.5% | Added |
| Capital International Investors | 2,626,644 | $25.6M | 0.01% | −5,505,307−67.7% | Reduced |
| Credit Suisse AG | 2,654,714 | $25.9M | 0.02% | +32,389+1.2% | Added |
| Lazard Asset Management LLC | 3,189,837 | $31.1M | 0.04% | +2,899,091+997.1% | Added |
| Guardian Capital Advisors LP | 3,836,414 | $34.6M | 3.37% | 00.0% | Unchanged |
| Founders Fund VII Management, LLC | 3,773,530 | $36.8M | 91.10% | 00.0% | Unchanged |
| Harvard Management Co Inc | 4,105,095 | $40.0M | 4.04% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 4,180,768 | $40.8M | 0.66% | 00.0% | Unchanged |
| DCVC Bio GP, LLC | 7,305,761 | $71.2M | 100.00% | 00.0% | Unchanged |
| SB Management Ltd | 7,764,299 | $75.7M | 14.78% | −2,052,891−20.9% | Reduced |
| Baker Bros. Advisors LP | 10,450,180 | $101.9M | 0.59% | 00.0% | Unchanged |
| Baillie Gifford & Co | 11,048,765 | $107.7M | 0.08% | +7,474,857+209.2% | Added |
| Allianz Asset Management GmbH | 11,158,045 | $108.8M | 0.09% | −6,965−0.1% | Reduced |
| Capital World Investors | 18,267,775 | $178.1M | 0.03% | −3,783,928−17.2% | Reduced |
| Swedbank AB | 0 | $0 | 0.00% | −1,951,940−100.0% | Sold out |
| Capital International Inc | 0 | $0 | 0.00% | −929,578−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −384,146−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −158,847−100.0% | Sold out |
| BlueCrest Capital Management Ltd | 0 | $0 | 0.00% | −143,307−100.0% | Sold out |
| Pentwater Capital Management LP | 0 | $0 | 0.00% | −137,500−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −84,531−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −70,700−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −55,200−100.0% | Sold out |
| Gotham Asset Management, LLC | 0 | $0 | 0.00% | −28,415−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −25,727−100.0% | Sold out |
| Scotia Capital Inc. | 0 | $0 | 0.00% | −13,127−100.0% | Sold out |
| Moloney Securities Asset Management, LLC | 0 | $0 | 0.00% | −13,100−100.0% | Sold out |
| Avidian Wealth Solutions, LLC | 0 | $0 | 0.00% | −12,600−100.0% | Sold out |
| Quantamental Technologies LLC | 0 | $0 | 0.00% | −12,080−100.0% | Sold out |
| Renaissance Capital LLC | 0 | $0 | 0.00% | −10,327−100.0% | Sold out |
| Eagle Bay Advisors LLC | 0 | $0 | 0.00% | −4,463−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Migdal Insurance & Financial Holdings Ltd. | 0 | $0 | 0.00% | −595−100.0% | Sold out |
| Bivin & Associates, Inc. | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Reilly Financial Advisors, LLC | – | – | – | – | Not filed |